Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma
Open Access
- 5 June 2015
- journal article
- research article
- Published by Springer Nature in Blood Cancer Journal
- Vol. 5 (6) , e318
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Gamma‐delta t‐cell lymphomasEuropean Journal of Haematology, 2014
- Hepatosplenic T-Cell Lymphoma: Clinicopathological Features and Treatment Outcomes: Report From The North American Peripheral T-Cell Lymphoma ConsortiumBlood, 2013
- Intensive Induction Chemotherapy Followed by Early High-Dose Therapy and Hematopoietic Stem Cell Transplantation Results in Improved Outcome for Patients with Hepatosplenic T-Cell Lymphoma: A Single Institution ExperienceClinical Lymphoma Myeloma and Leukemia, 2013
- Hepatosplenic αβ T-cell lymphoma associated with azathioprine therapyInternational Journal of Hematology, 2012
- Hepatosplenic T-cell lymphoma in patients receiving TNF-α inhibitor therapyEuropean Journal of Gastroenterology & Hepatology, 2011
- Hepatosplenic T-cell lymphoma and inflammatory bowel diseaseJournal of Crohn's and Colitis, 2010
- Hepatosplenic and Other γΔ T-Cell LymphomasAmerican Journal of Clinical Pathology, 2007
- Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphomaLeukemia & Lymphoma, 2007
- Hepatosplenic 33 T-Cell Lymphoma with Myelodysplastic SyndromeInternational Journal of Hematology, 2005
- Long-Term Survival With Allogeneic Stem Cell Transplant and Donor Lymphocyte Infusion Following Salvage Therapy with Anti-CD52 Monoclonal Antibody (Campath) in a Patient with α/β Hepatosplenic T-Cell Non-Hodgkin's LymphomaLeukemia & Lymphoma, 2004